Health CareMedical Equipment and Services
  • Price (USD)505.80
  • Today's Change-2.04 / -0.40%
  • Shares traded46.00k
  • 1 Year change-20.17%
  • Beta0.9299
Data delayed at least 15 minutes, as of Jun 27 2022 15:19 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade Bio Rad Laboratories Inc (BIO:NYQ) traded at 505.80, 9.34% above its 52-week low of 462.61, set on Jun 17, 2022.
52-week range
462.61Jun 17 2022832.70Sep 02 2021
Markit short selling activity
Previous close507.84
Average volume178.21k
Shares outstanding29.94m
Free float21.46m
P/E (TTM)--
Market cap15.02bn USD
EPS (TTM)-4.88
Data delayed at least 15 minutes, as of Jun 27 2022 15:19 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.